TY - JOUR
T1 - Conservative management for postmenopausal women with tubo-ovarian abscess
AU - Yagur, Yael
AU - Weitzner, Omer
AU - Man-El, Gili
AU - Schonman, Ron
AU - Klein, Zvi
AU - Fishman, Ami
AU - Beiner, Mario
AU - Kadan, Yfat
N1 - Publisher Copyright:
© 2019 by The North American Menopause Society.
PY - 2019/7/1
Y1 - 2019/7/1
N2 - Objectives:The aim of the study was to describe the experience of one institution in management and outcome of tubo-ovarian abscess (TOA) in pre-and postmenopausal women and to reassess the optimal approach for TOA in postmenopausal women.Methods:A retrospective cohort study included women diagnosed with TOA between 2003 and 2017 in a tertiary referral center. TOA was diagnosed by sonography or computerized tomography and at least one of the following criteria: temperature more than 38°C, leukocytosis more than 15,000 mm3, or surgically proven disease. Women were followed up for a mean of 7.6 years (range 6 mo to 14 y). The rates of conservative management and pelvic malignancy were evaluated.Results:The study cohort included 144 (69.23%) women who met the inclusion criteria, of which 105 (72.92%) were premenopausal and 39 (27.08%) were postmenopausal. Univariate analysis found no differences in risk factors and disease characteristics between the two groups. Among the study sample, 22 (56.4%) postmenopausal women and 48 (45.7%) premenopausal women were treated surgically (P = 0.5). None of the premenopausal women and 1 (2.6%) postmenopausal woman were diagnosed with pelvic malignancy.Conclusion:In postmenopausal women with TOA, the prevalence of concurrent pelvic malignancy was 2.6%, which is higher than in the general population, but lower than that reported in the literature; 44% were conservatively managed without any apparent cases of misdiagnoses of cancer.
AB - Objectives:The aim of the study was to describe the experience of one institution in management and outcome of tubo-ovarian abscess (TOA) in pre-and postmenopausal women and to reassess the optimal approach for TOA in postmenopausal women.Methods:A retrospective cohort study included women diagnosed with TOA between 2003 and 2017 in a tertiary referral center. TOA was diagnosed by sonography or computerized tomography and at least one of the following criteria: temperature more than 38°C, leukocytosis more than 15,000 mm3, or surgically proven disease. Women were followed up for a mean of 7.6 years (range 6 mo to 14 y). The rates of conservative management and pelvic malignancy were evaluated.Results:The study cohort included 144 (69.23%) women who met the inclusion criteria, of which 105 (72.92%) were premenopausal and 39 (27.08%) were postmenopausal. Univariate analysis found no differences in risk factors and disease characteristics between the two groups. Among the study sample, 22 (56.4%) postmenopausal women and 48 (45.7%) premenopausal women were treated surgically (P = 0.5). None of the premenopausal women and 1 (2.6%) postmenopausal woman were diagnosed with pelvic malignancy.Conclusion:In postmenopausal women with TOA, the prevalence of concurrent pelvic malignancy was 2.6%, which is higher than in the general population, but lower than that reported in the literature; 44% were conservatively managed without any apparent cases of misdiagnoses of cancer.
KW - Conservative management
KW - Pelvic malignancy
KW - Tubo-ovarian abscess
UR - http://www.scopus.com/inward/record.url?scp=85067619356&partnerID=8YFLogxK
U2 - 10.1097/GME.0000000000001317
DO - 10.1097/GME.0000000000001317
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30889091
AN - SCOPUS:85067619356
SN - 1072-3714
VL - 26
SP - 793
EP - 796
JO - Menopause
JF - Menopause
IS - 7
ER -